Fibrosis markers. by Dwight D. Harris (14484648)

Synthesis and Antiproliferative Activity of a New Series of Mono- and Bis(dimethylpyrazolyl)‑<i>s</i>‑triazine Derivatives Targeting EGFR/PI3K/AKT/mTOR Signaling Cascades by Ihab Shawish (13015516)

Subjects:

Synthesis and Antiproliferative Activity of a New Series of Mono- and Bis(dimethylpyrazolyl)‑<i>s</i>‑triazine Derivatives Targeting EGFR/PI3K/AKT/mTOR Signaling Cascades by Ihab Shawish (13015516)

Subjects:

Decreased BK responsiveness of ERK activation is found only in PS-1 FAD mutant AD fibroblasts. by Graziella Mendonsa (374346)

Decreased MMP-9 protein expression induced by STIP1 knockdown is independent of common signaling pathways. by Hsin-Shih Wang (8802)

“…(B) Decreased MMP-9 protein expression induced by siRNA knockdown of STIP1 was unaffected by exposure either to the DNA methylation inhibitor 5-aza-2’-deoxycytidine (AZA; 10 μM) or the histone deacetylase inhibitor trichostatin A (TSA; 20 nM). …”

Down-regulation of GPER reverses the decreased expression of PCNA and cell morphology changes caused by G-1. by Fen Li (337013)

A647D mutation decreases I_Na of WT and P1332L when co-expressed. by Jie Liu (15128)

Immunoblotting for TGF-beta, alpha-actinin, MMP-13, and mTOR. by Dwight D. Harris (14484648)

Immunoblotting for JAK, STAT, and SMAD. by Dwight D. Harris (14484648)

Immunoblotting for insulin sensitivity markers. by Dwight D. Harris (14484648)

Extended Ensemble Molecular Dynamics Study of Ammonia–Cellulose I Complex Crystal Models: Free-Energy Landscape and Atomistic Pictures of Ammonia Diffusion in the Crystalline Phase... by Toshifumi Yui (1768846)

Subjects:

Extended Ensemble Molecular Dynamics Study of Ammonia–Cellulose I Complex Crystal Models: Free-Energy Landscape and Atomistic Pictures of Ammonia Diffusion in the Crystalline Phase... by Toshifumi Yui (1768846)

Subjects:

Extended Ensemble Molecular Dynamics Study of Ammonia–Cellulose I Complex Crystal Models: Free-Energy Landscape and Atomistic Pictures of Ammonia Diffusion in the Crystalline Phase... by Toshifumi Yui (1768846)

Subjects:

Hazard Ratios (HRs) and 95% CI for cancer per tertile decrease in DII, and tertile increase in MDS, at baseline in all participants (n = 100,881), men (n = 49,880), and women (n =... by Stina Bodén (3905218)

Immunoblotting FOXO1 and insulin receptors. by Dwight D. Harris (14484648)

Decreased E/I synapse ratio and loss of cortico-LA synaptic plasticity in the absence of coronin 1. by Rajesh Jayachandran (542641)

“…Scale bar, 2 microns. Data shown are mean values ± SD, <i>p</i><0.01. (C) Hippocampal neurons were labeled using anti-vGLUT1 and anti-vGAT antibodies, followed by Alex Fluor 488 or 568 labeled secondary antibodies, respectively. …”

Tonic nM DA stabilizes the timing of LP activity over the short term. by Wulf-Dieter C. Krenz (693267)

“…<p><b>(A) Pyloric output is altered by 1mM 4AP</b>. Representative experiments showing the motor output at three time points for a preparation continuously superfused with 1mM 4AP (blue) or 1mM 4AP + 5nM DA (green) beginning at t = 0. …”

Average giving in the 5€, 100€, and 1000€ treatments. by Pablo Brañas-Garza (336425)

Length-Dependent Convergence and Saturation Behavior of Electrochemical, Linear Optical, Quadratic Nonlinear Optical, and Cubic Nonlinear Optical Properties of Dipolar Alkynylruthe... by Bandar Babgi (2360545)

“…The syntheses of <i>trans</i>-[Ru{4,4′-CCC₆H₂[2,5-(OEt)₂]CCC₆H₄NO₂}Cl(dppm)₂] (<b>19</b>), <i>trans</i>-[Ru{4,4′,4′′-CCC₆H₄CCC₆H₂[2,5-(OEt)₂]CCC₆H₄NO₂}Cl(dppm)₂] (<b>20</b>), <i>trans</i>-[Ru{4,4′,4′′,4′′′-CCC₆H₄CCC₆H₂[2,5-(OEt)₂]CCC₆H₂[2,5-(OEt)₂]CCC₆H₄NO₂}Cl(dppe)₂] (<b>21</b>), <i>trans</i>-[Ru{4,4′,4′′,4′′′-CCC₆H₄CCC₆H₂[2,5-(OEt)₂]CCC₆H₂[2,5-(OEt)₂]CCC₆H₄NO₂}Cl(dppm)₂] (<b>22</b>), <i>trans</i>-[Ru{4,4′,4′′,4′′′-CCC₆H₄CCC₆H₄CCC₆H₂[2,5-(OEt)₂]CCC₆H₄NO₂}Cl(dppm)₂] (<b>23</b>), and <i>trans</i>-[Ru{4,4′,4′′,4′′′,4′′′′-CCC₆H₄CCC₆H₄CCC₆H₂[2,5-(OEt)₂]CCC₆H₂[2,5-(OEt)₂]CCC₆H₄NO₂}Cl(dppm)₂] (<b>24</b>) are reported, together with those of precursor alkynes, complexes with the donor−π-bridge−acceptor formulation that affords efficient quadratic and cubic NLO compounds; the identity of <b>19</b> was confirmed by a structural study. …”

Decrease in vRNA in brain during antiretroviral therapy. by Sonny R. Elizaldi (9684796)